Albemarle (NYSE: ALB) reported Q3 EPS of ($1.55), $1.11 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.37 billion.

For earnings history and earnings-related data on Albemarle (ALB) click here.